Advertisement
Review Article| Volume 234, P114-128, August 2021

Mind-body approaches targeting the psychological aspects of opioid use problems in patients with chronic pain: evidence and opportunities

  • Marc O. Martel
    Affiliations
    Faculty of Dentistry & Department of Anesthesiology, McGill University, Montreal, Canada

    Division of Experimental Medicine, McGill University, Montreal, Canada
    Search for articles by this author
  • Alice Bruneau
    Affiliations
    Division of Experimental Medicine, McGill University, Montreal, Canada
    Search for articles by this author
  • Robert R. Edwards
    Correspondence
    Reprint requests: Robert R. Edwards, Department of Anesthesiology & Pain Medicine, Brigham & Women's Hospital, Harvard Medical School, 850 Boylston Street, Chestnut Hill, MA 02467, USA.
    Affiliations
    Department of Anesthesiology & Pain Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts
    Search for articles by this author
Published:March 03, 2021DOI:https://doi.org/10.1016/j.trsl.2021.02.013
      Opioids are commonly prescribed for the management of patients with chronic noncancer pain. Despite the potential analgesic benefits of opioids, long-term opioid therapy (LTOT) may be accompanied by problems such as opioid misuse and opioid use disorder (OUD). In this review, we begin with a description of opioid misuse and OUD and the patient-specific factors associated with these problems among patients with chronic pain. We will focus primarily on highlighting the predominant role played by psychological factors in the occurrence of opioid misuse and OUD in these patients. Several psychological factors have been found to be associated with opioid use problems in patients with chronic pain, and evidence indicates that patients presenting with psychological disturbances are particularly at risk of transitioning to long-term opioid use, engaging in opioid misuse behaviors, and developing OUD. The biological factors that might underlie the association between psychological disturbances and opioid use problems in patients with chronic pain have yet to be fully elucidated, but a growing number of studies suggest that dysfunctions in reward, appetitive, autonomic, and neurocognitive systems might be involved. We end with an overview of specific types of psychological interventions that have been put forward to prevent or reduce the occurrence of opioid misuse and OUD in patients with chronic pain who are prescribed LTOT.

      Abbreviations:

      LTOT (Long-term opioid therapy), OUD (Opioid use disorder)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Busse JW
        • Wang L
        • Kamaleldin M
        • Craigie S
        • Riva JJ
        • Montoya L
        • et al.
        Opioids for chronic noncancer pain: a systematic review and meta-analysis.
        Jama. 2018; 320: 2448-2460
        • Chou R.
        Review: Opioids improve chronic noncancer pain, but difference may not be clinically meaningful in most patients.
        Ann Intern Med. 2019; 170: Jc41
        • Turk DC
        • Swanson KS
        • Gatchel RJ.
        Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis.
        Clin J Pain. 2008; 24: 497-508
        • Vowles KE
        • McEntee ML
        • Julnes PS
        • Frohe T
        • Ney JP
        • van der Goes DN.
        Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis.
        Pain. 2015; 156: 569-576
        • Becker WC
        • Merlin JS
        • Manhapra A
        • Edens EL.
        Management of patients with issues related to opioid safety, efficacy and/or misuse: a case series from an integrated, interdisciplinary clinic.
        Addict Sci Clin Pract. 2016; 11: 3
        • Sullivan M.
        Clarifying opioid misuse and abuse.
        Pain. 2013; 154: 2239-2240
        • Becker WC
        • Fraenkel L
        • Edelman EJ
        • et al.
        Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: a systematic review.
        Pain. 2013; 154: 905-916
        • Chou R
        • Turner JA
        • Devine EB
        • et al.
        The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.
        Ann Intern Med. 2015; 162: 276-286
      1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC2013.

        • Porter J
        • Jick H.
        Addiction rare in patients treated with narcotics.
        N Engl J Med. 1980; 302: 123
        • Sullivan MD
        • Edlund MJ
        • Fan MY
        • Devries A
        • Brennan Braden J
        • Martin BC.
        Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study.
        Pain. 2010; 150: 332-339
        • Cepeda MS
        • Fife D
        • Ma Q
        • Ryan PB.
        Comparison of the risks of opioid abuse or dependence between tapentadol and oxycodone: results from a cohort study.
        J Pain. 2013; 14: 1227-1241
        • Edlund MJ
        • Martin BC
        • Fan MY
        • Devries A
        • Braden JB
        • Sullivan MD.
        Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study.
        Drug Alcohol Depend. 2010; 112: 90-98
        • Edlund MJ
        • Martin BC
        • Russo JE
        • DeVries A
        • Braden JB
        • Sullivan MD.
        The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription.
        Clin J Pain. 2014; 30: 557-564
        • Huffman KL
        • Shella ER
        • Sweis G
        • Griffith SD
        • Scheman J
        • Covington EC.
        Nonopioid substance use disorders and opioid dose predict therapeutic opioid addiction.
        J Pain. 2015; 16: 126-134
        • Cragg A
        • Hau JP
        • Woo SA
        • et al.
        Risk Factors for Misuse of Prescribed Opioids: A Systematic Review and Meta-Analysis.
        Ann Emerg Med. 2019; 74: 634-646
        • Fleming MF
        • Davis J
        • Passik SD.
        Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients.
        Pain Med. 2008; 9: 1098-1106
        • Turner JA
        • Saunders K
        • Shortreed SM
        • et al.
        Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results.
        J Gen Intern Med. 2014; 29: 1663-1671
        • Rogers AM
        • Kauffman BM
        • Bakhshaie JM
        • McHugh RKP
        • Ditre JWP
        • Zvolensky MJP.
        Anxiety sensitivity and opioid misuse among opioid-using adults with chronic pain.
        Am J Drug Alcohol Abuse. 2019; 45: 470-478
        • Grattan A
        • Sullivan MD
        • Saunders KW
        • Campbell CI
        • Von Korff MR.
        Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse.
        Ann Fam Med. 2012; 10: 304-311
        • Edlund MJ
        • Steffick D
        • Hudson T
        • Harris KM
        • Sullivan M.
        Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain.
        Pain. 2007; 129: 355-362
        • Argoff CE
        • Viscusi ER.
        The use of opioid analgesics for chronic pain: minimizing the risk for harm.
        Am J Gastroenterol Suppl. 2014; 2: 3-8
        • Cheatle MD
        • Barker C.
        Improving opioid prescription practices and reducing patient risk in the primary care setting.
        J Pain Res. 2014; 7: 301-311
        • Jamison RN
        • Serraillier J
        • Michna E.
        Assessment and treatment of abuse risk in opioid prescribing for chronic pain.
        Pain Res Treat. 2011; 2011941808
        • Merrill JO
        • Duncan MH.
        Addiction disorders.
        Med Clin North Am. 2014; 98: 1097-1122
        • Klimas J
        • Gorfinkel L
        • Fairbairn N
        • et al.
        Strategies to Identify Patient Risks of Prescription Opioid Addiction When Initiating Opioids for Pain: A Systematic Review.
        JAMA Netw Open. 2019; 2e193365
        • Boscarino JA
        • Hoffman SN
        • Han JJ.
        Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates.
        Subst Abuse Rehabil. 2015; 6: 83-91
        • Boscarino JA
        • Rukstalis M
        • Hoffman SN
        • et al.
        Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system.
        Addiction. 2010; 105: 1776-1782
        • Martel MO
        • Shir Y
        • Ware MA.
        Substance-related disorders: A review of prevalence and correlates among patients with chronic pain.
        Prog Neuropsychopharmacol Biol Psychiatry. 2018; 87: 245-254
        • Rogers AH
        • Shepherd JM
        • Orr MF
        • Bakhshaie J
        • McHugh RK
        • Zvolensky MJ.
        Exploring anxiety sensitivity in the relationship between pain intensity and opioid misuse among opioid-using adults with chronic pain.
        J Psychiatr Res. 2019; 111: 154-159
        • Zegel M
        • Rogers AH
        • Vujanovic AA
        • Zvolensky MJ.
        Alcohol use problems and opioid misuse and dependence among adults with chronic pain: The role of distress tolerance.
        Psychol Addict Behav. 2020;
        • Martel MO
        • Dolman AJ
        • Edwards RR
        • Jamison RN
        • Wasan AD.
        The association between negative affect and prescription opioid misuse in patients with chronic pain: the mediating role of opioid craving.
        J Pain. 2014; 15: 90-100
        • Schieffer BM
        • Pham Q
        • Labus J
        • et al.
        Pain medication beliefs and medication misuse in chronic pain.
        J Pain. 2005; 6: 620-629
        • Martel MO
        • Edwards RR
        • Jamison RN.
        The relative contribution of pain and psychological factors to opioid misuse: a 6-month observational study.
        Am Psychol. 2020; 75: 772-783
        • Campbell G
        • Noghrehchi F
        • Nielsen S
        • et al.
        Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: findings from a 5-year prospective cohort study.
        EClinicalMedicine. 2020; 28100592
        • Frimerman L
        • Verner M
        • Sirois A
        • et al.
        Day-to-day hedonic and calming effects of opioids, opioid craving, and opioid misuse among patients with chronic pain prescribed long-term opioid therapy.
        PAIN. 2021; https://doi.org/10.1097/j.pain.0000000000002220
        • Edwards RR
        • Dworkin RH
        • Sullivan MD
        • Turk DC
        • Wasan AD.
        The role of psychosocial processes in the development and maintenance of chronic pain.
        J Pain. 2016; 17: T70-T92
        • Turk DC
        • Fillingim RB
        • Ohrbach R
        • Patel KV.
        Assessment of Psychosocial and Functional Impact of Chronic Pain.
        J Pain. 2016; 17: T21-T49
        • Kerns RD
        • Sellinger J
        • Goodin BR.
        Psychological treatment of chronic pain.
        Annu Rev Clin Psychol. 2011; 7: 411-434
        • Gatchel RJ.
        Comorbidity of chronic pain and mental health disorders: the biopsychosocial perspective.
        Am Psychol. 2004; 59: 795-805
        • Dersh J
        • Mayer T
        • Theodore BR
        • Polatin P
        • Gatchel RJ.
        Do psychiatric disorders first appear preinjury or postinjury in chronic disabling occupational spinal disorders?.
        Spine (Phila Pa 1976). 2007; 32: 1045-1051
        • Dersh J
        • Gatchel RJ
        • Mayer T
        • Polatin P
        • Temple OR.
        Prevalence of psychiatric disorders in patients with chronic disabling occupational spinal disorders.
        Spine (Phila Pa 1976). 2006; 31: 1156-1162
        • Demyttenaere K
        • Bruffaerts R
        • Lee S
        • et al.
        Mental disorders among persons with chronic back or neck pain: results from the World Mental Health Surveys.
        Pain. 2007; 129: 332-342
        • Howe CQ
        • Sullivan MD.
        The missing 'P' in pain management: how the current opioid epidemic highlights the need for psychiatric services in chronic pain care.
        Gen Hosp Psychiatry. 2014; 36: 99-104
        • Jamison RN
        • Edwards RR.
        Integrating pain management in clinical practice.
        J Clin Psychol Med Settings. 2012; 19: 49-64
        • Rogers AH
        • Bakhshaie J
        • Zvolensky MJ
        • Vowles KE.
        Pain anxiety as a mechanism linking pain severity and opioid misuse and disability among individuals with chronic pain.
        J Addict Med. 2020; 14: 26-31
        • Rogers AH
        • Bakhshaie J
        • Lam H
        • Langdon KJ
        • Ditre JW
        • Zvolensky MJ.
        Pain-related anxiety and opioid misuse in a racially/ethnically diverse young adult sample with moderate/severe pain.
        Cogn Behav Ther. 2018; 47: 372-382
        • Morasco BJ
        • Duckart JP
        • Dobscha SK.
        Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder.
        J Gen Intern Med. 2011; 26: 965-971
        • Williams JR
        • Cole V
        • Girdler S
        • Cromeens MG.
        Exploring stress, cognitive, and affective mechanisms of the relationship between interpersonal trauma and opioid misuse.
        PLoS One. 2020; 15e0233185
        • López-Martínez AE
        • Reyes-Pérez Á
        • Serrano-Ibáñez ER
        • Esteve R
        • Ramírez-Maestre C.
        Chronic pain, posttraumatic stress disorder, and opioid intake: a systematic review.
        World J Clin Cases. 2019; 7: 4254-4269
        • Bilevicius E
        • Sommer JL
        • Asmundson GJG
        • El-Gabalawy R.
        Posttraumatic stress disorder and chronic pain are associated with opioid use disorder: Results from a 2012-2013 American nationally representative survey.
        Drug Alcohol Depend. 2018; 188: 119-125
        • Edlund MJ
        • Sullivan MD
        • Han X
        • Booth BM.
        Days with pain and substance use disorders: is there an association?.
        Clin J Pain. 2013; 29: 689-695
        • Edlund MJ
        • Sullivan M
        • Steffick D
        • Harris KM
        • Wells KB.
        Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?.
        Pain Med. 2007; 8: 647-656
        • Park J
        • Lavin R.
        Risk factors associated with opioid medication misuse in community-dwelling older adults with chronic pain.
        Clin J Pain. 2010; 26: 647-655
        • Trafton JA
        • Cucciare MA
        • Lewis E
        • Oser M.
        Somatization is associated with non-adherence to opioid prescriptions.
        J Pain. 2011; 12: 573-580
        • Garland EL
        • Trostheim M
        • Eikemo M
        • Ernst G
        • Leknes S.
        Anhedonia in chronic pain and prescription opioid misuse.
        Psychol Med. 2019; : 1-12
        • Scherrer JF
        • Svrakic DM
        • Freedland KE
        • et al.
        Prescription opioid analgesics increase the risk of depression.
        J Gen Intern Med. 2014; 29: 491-499
        • Scherrer JF
        • Salas J
        • Copeland LA
        • et al.
        Increased Risk of depression recurrence after initiation of prescription opioids in noncancer pain patients.
        J Pain. 2016; 17: 473-482
        • Scherrer JF
        • Salas J
        • Copeland LA
        • Stock EM
        • Ahmedani BK
        • Sullivan MD
        • et al.
        Prescription opioid duration, dose, and increased risk of depression in 3 large patient populations.
        Ann Fam Med. 2016; 14: 54-62
        • Salas J
        • Scherrer JF
        • Schneider FD
        • Sullivan MD
        • Bucholz KK
        • Burroughs T
        • et al.
        New-onset depression following stable, slow, and rapid rate of prescription opioid dose escalation.
        Pain. 2017; 158: 306-312
        • Zautra A
        • Smith B
        • Affleck G
        • Tennen H.
        Examinations of chronic pain and affect relationships: applications of a dynamic model of affect.
        J Consult Clin Psychol. 2001; 69: 786-795
        • Wasan AD
        • Michna E
        • Edwards RR
        • Katz JN
        • Nedeljkovic SS
        • Dolman AJ
        • et al.
        Psychiatric Comorbidity Is Associated Prospectively with Diminished Opioid Analgesia and Increased Opioid Misuse in Patients with Chronic Low Back Pain.
        Anesthesiology. 2015; 123: 861-872
        • Wasan AD
        • Butler SF
        • Budman SH
        • Benoit C
        • Fernandez K
        • Jamison RN.
        Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
        Clin J Pain. 2007; 23: 307-315
        • Webster LR
        • Webster RM.
        Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool.
        Pain Med. 2005; 6: 432-442
        • Hah JM
        • Sturgeon JA
        • Zocca J
        • Sharifzadeh Y
        • Mackey SC.
        Factors associated with prescription opioid misuse in a cross-sectional cohort of patients with chronic non-cancer pain.
        J Pain Res. 2017; 10: 979-987
        • Gilam G
        • Sturgeon JA
        • You DS
        • Wasan AD
        • Darnall BD
        • Mackey SC.
        Negative affect-related factors have the strongest association with prescription opioid misuse in a cross-sectional cohort of patients with chronic pain.
        Pain Med. 2020; 21: e127-ee38
        • Edwards RR
        • Cahalan C
        • Mensing G
        • Smith M
        • Haythornthwaite JA.
        Pain, catastrophizing, and depression in the rheumatic diseases.
        Nat Rev Rheumatol. 2011; 7: 216-224
        • Sullivan MJL
        • Martel MO.
        Processes Underlying the Relation between Catastrophizing and Chronic Pain: Implications for Intervention.
        in: Hasenbring M Rusu A. Turk D.C. From Acute to Chronic Back Pain: Risk factors, Mechanisms and Clinical Implications. Oxford University Press, Oxford2011
        • Quartana PJ
        • Campbell CM
        • Edwards RR.
        Pain catastrophizing: a critical review.
        Expert Rev Neurother. 2009; 9: 745-758
        • Sullivan MJ
        • Thorn B
        • Haythornthwaite JA
        • Keefe F
        • Martin M
        • Bradley LA
        • et al.
        Theoretical perspectives on the relation between catastrophizing and pain.
        Clin J Pain. 2001; 17: 52-64
        • Edwards RR
        • Bingham 3rd, CO
        • Bathon J
        • Haythornthwaite JA.
        Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases.
        Arthritis Rheum. 2006; 55: 325-332
        • Arteta J
        • Cobos B
        • Hu Y
        • Jordan K
        • Howard K.
        Evaluation of how depression and anxiety mediate the relationship between pain catastrophizing and prescription opioid misuse in a chronic pain population.
        Pain Med. 2016; 17: 295-303
        • Lee S-J
        • Koussa M
        • Gelberg L
        • Heinzerling K
        • Young SD.
        Somatization, mental health and pain catastrophizing factors associated with risk of opioid misuse among patients with chronic non-cancer pain.
        J Substance Use. 2020; 25: 357-362
        • Vest N
        • Reynolds CJ
        • Tragesser SL.
        Impulsivity and risk for prescription opioid misuse in a chronic pain patient sample.
        Addict Behav. 2016; 60: 184-190
        • Reynolds CJ
        • Vest N
        • Tragesser SL.
        Borderline personality disorder features and risk for prescription opioid misuse in a chronic pain sample: roles for identity disturbances and impulsivity.
        J Pers Disord. 2019; : 1-18
        • Verdejo-Garcia A
        • Lawrence AJ
        • Clark L.
        Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies.
        Neurosci Biobehav Rev. 2008; 32: 777-810
        • Ebner-Priemer UW
        • Welch SS
        • Grossman P
        • Reisch T
        • Linehan MM
        • Bohus M.
        Psychophysiological ambulatory assessment of affective dysregulation in borderline personality disorder.
        Psychiatry Res. 2007; 150: 265-275
        • Ebner-Priemer UW
        • Kuo J
        • Kleindienst N
        • et al.
        State affective instability in borderline personality disorder assessed by ambulatory monitoring.
        Psychol Med. 2007; 37: 961-970
        • Turner D
        • Sebastian A
        • Tüscher O.
        Impulsivity and cluster B personality disorders.
        Curr Psychiatry Rep. 2017; 19: 15
        • Reynolds CJ
        • Tragesser SL.
        Borderline personality disorder features are associated with concurrent pain-related disability in a chronic pain sample.
        Pain Med. 2019; 20: 233-245
        • Bernardes SF
        • Lima ML.
        Being less of a man or less of a woman: perceptions of chronic pain patients' gender identities.
        Eur J Pain. 2010; 14: 194-199
        • McCracken LM
        • Velleman SC.
        Psychological flexibility in adults with chronic pain: a study of acceptance, mindfulness, and values-based action in primary care.
        Pain. 2010; 148: 141-147
        • Vowles KE
        • McCracken LM.
        Comparing the role of psychological flexibility and traditional pain management coping strategies in chronic pain treatment outcomes.
        Behav Res Ther. 2010; 48: 141-146
        • Drummond DC.
        Theories of drug craving, ancient and modern.
        Addiction. 2001; 96: 33-46
        • Tiffany ST
        • Wray JM.
        The clinical significance of drug craving.
        Ann N Y Acad Sci. 2012; 1248: 1-17
        • Wasan AD
        • Ross EL
        • Michna E
        • et al.
        Craving of prescription opioids in patients with chronic pain: a longitudinal outcomes trial.
        J Pain. 2012; 13: 146-154
        • Wasan AD
        • Butler SF
        • Budman SH
        • et al.
        Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients?.
        Clin J Pain. 2009; 25: 193-198
        • Garland EL
        • Howard MO
        Opioid attentional bias and cue-elicited craving predict future risk of prescription opioid misuse among chronic pain patients.
        Drug Alcohol Depend. 2014; 144: 283-287
        • Butler SF
        • Fernandez K
        • Benoit C
        • Budman SH
        • Jamison RN.
        Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R).
        J Pain. 2008; 9: 360-372
        • Von Korff M
        • Walker RL
        • Saunders K
        • et al.
        Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives.
        Int J Drug Policy. 2017; 46: 90-98
        • Garland EL
        • Brown SM
        • Howard MO.
        Thought suppression as a mediator of the association between depressed mood and prescription opioid craving among chronic pain patients.
        J Behav Med. 2016; 39: 128-138
        • Martel MO
        • Finan PH
        • McHugh RK
        • et al.
        Day-to-day pain symptoms are only weakly associated with opioid craving among patients with chronic pain prescribed opioid therapy.
        Drug Alcohol Depend. 2016; 162: 130-136
        • Martel MO
        • Jamison RN
        • Wasan AD
        • Edwards RR.
        The association between catastrophizing and craving in patients with chronic pain prescribed opioid therapy: A preliminary analysis.
        Pain Med. 2014; 15: 1757-1764
        • Jensen MP
        • Turner JA
        • Romano JM
        • Karoly P.
        Coping with chronic pain: a critical review of the literature.
        Pain. 1991; 47: 249-283
        • Jensen MP
        • Turner JA
        • Romano JM.
        Self-efficacy and outcome expectancies: relationship to chronic pain coping strategies and adjustment.
        Pain. 1991; 44: 263-269
        • Turner JA
        • Jensen MP
        • Romano JM.
        Do beliefs, coping, and catastrophizing independently predict functioning in patients with chronic pain?.
        Pain. 2000; 85: 115-125
        • Lefebvre JC
        • Keefe FJ
        • Affleck G
        • et al.
        The relationship of arthritis self-efficacy to daily pain, daily mood, and daily pain coping in rheumatoid arthritis patients.
        Pain. 1999; 80: 425-435
        • Affleck G
        • Tennen H
        • Urrows S
        • Higgins P.
        Neuroticism and the pain-mood relation in rheumatoid arthritis: insights from a prospective daily study.
        J Consult Clin Psychol. 1992; 60: 119-126
        • Wasan AD
        • Davar G
        • Jamison R.
        The association between negative affect and opioid analgesia in patients with discogenic low back pain.
        Pain. 2005; 117: 450-461
        • Passik SD
        • Lowery A.
        Psychological variables potentially implicated in opioid-related mortality as observed in clinical practice.
        Pain Med. 2011; 12: S36-S42
        • Khantzian EJ.
        The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence.
        Am J Psychiatry. 1985; 142: 1259-1264
        • Kirsh KL
        • Jass C
        • Bennett DS
        • Hagen JE
        • Passik SD.
        Initial development of a survey tool to detect issues of chemical coping in chronic pain patients.
        Palliat Support Care. 2007; 5: 219-226
        • Manhapra A
        • Becker WC.
        Pain and addiction: an integrative therapeutic approach.
        Med Clin North Am. 2018; 102: 745-763
        • Ferguson E
        • Zale E
        • Ditre J
        • et al.
        CANUE: a theoretical model of pain as an antecedent for substance use.
        Ann Behav Med. 2020;
        • Vowles KE
        • Bailey RW
        • McEntee ML
        • Pielech M
        • Edwards KA
        • Bolling LA
        • et al.
        Using analgesics for emotional modulation is associated with increased distress, depression, and risk of opioid and alcohol misuse: initial evaluation and component analysis of the Reasons for Analgesic Use Measure (RAUM).
        Clin J Pain. 2018; 34: 975-982
        • Garland EL
        • Bryan CJ
        • Nakamura Y
        • Froeliger B
        • Howard MO.
        Deficits in autonomic indices of emotion regulation and reward processing associated with prescription opioid use and misuse.
        Psychopharmacology (Berl). 2017; 234: 621-629
        • Garland EL
        • Hanley AW
        • Bedford CE
        • et al.
        Reappraisal deficits promote craving and emotional distress among chronic pain patients at risk for prescription opioid misuse.
        J Addict Dis. 2018; 37: 14-22
        • Campbell CM
        • Witmer K
        • Simango M
        • et al.
        Catastrophizing delays the analgesic effect of distraction.
        Pain. 2010; 149: 202-207
        • Keefe FJ
        • Affleck G
        • France CR
        • et al.
        Gender differences in pain, coping, and mood in individuals having osteoarthritic knee pain: a within-day analysis.
        Pain. 2004; 110: 571-577
        • Sullivan MJ
        • Adams H
        • Sullivan ME.
        Communicative dimensions of pain catastrophizing: social cueing effects on pain behaviour and coping.
        Pain. 2004; 107: 220-226
        • Finan PH
        • Buenaver LF
        • Coryell VT
        • Smith MT.
        Cognitive-behavioral therapy for comorbid insomnia and chronic pain.
        Sleep Med Clin. 2014; 9: 261-274
        • Smith MT
        • Haythornthwaite JA.
        How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature.
        Sleep Med Rev. 2004; 8: 119-132
        • Herrero Babiloni A
        • De Koninck BP
        • Beetz G
        • De Beaumont L
        • Martel MO
        • Lavigne GJ
        Sleep and pain: recent insights, mechanisms, and future directions in the investigation of this relationship.
        J Neural Transmission (Vienna, Austria: 1996). 2020; 127: 647-660
        • Morasco BJ
        • O'Hearn D
        • Turk DC
        • Dobscha SK.
        Associations between prescription opioid use and sleep impairment among veterans with chronic pain.
        Pain Med. 2014; 15: 1902-1910
        • Kelley ML
        • Bravo AJ
        • Votaw VR
        • Stein E
        • Redman JC
        • Witkiewitz K.
        Opioid and sedative misuse among veterans wounded in combat.
        Addict Behav. 2019; 92: 168-172
        • Groenewald CB
        • Law EF
        • Rabbitts JA
        • Palermo TM.
        Associations between adolescent sleep deficiency and prescription opioid misuse in adulthood.
        Sleep. 2021 Mar 12; 44: zsaa201https://doi.org/10.1093/sleep/zsaa201
        • Smith MT
        • Huang MI
        • Manber R.
        Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders.
        Clin Psychol Rev. 2005; 25: 559-592
        • Campbell CM
        • Buenaver LF
        • Finan P
        • et al.
        Sleep, pain catastrophizing, and central sensitization in knee osteoarthritis patients with and without insomnia.
        Arthritis Care Res (Hoboken). 2015; 67: 1387-1396
        • Buenaver LF
        • Quartana PJ
        • Grace EG
        • Sarlani E
        • Simango M
        • Edwards RR
        • et al.
        Evidence for indirect effects of pain catastrophizing on clinical pain among myofascial temporomandibular disorder participants: the mediating role of sleep disturbance.
        Pain. 2012; 153: 1159-1166
        • Burgess HJ
        • Burns JW
        • Buvanendran A
        • et al.
        Associations between sleep disturbance and chronic pain intensity and function: a test of direct and indirect pathways.
        Clin J Pain. 2019; 35: 569-576
        • Kreek MJ
        • Levran O
        • Reed B
        • Schlussman SD
        • Zhou Y
        • Butelman ER.
        Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.
        J Clin Invest. 2012; 122: 3387-3393
        • Kosten TR
        • George TP.
        The neurobiology of opioid dependence: implications for treatment.
        Sci Pract Perspect. 2002; 1: 13-20
        • Koob GF.
        Addiction is a reward deficit and stress surfeit dIsorder.
        Front Psychiatry. 2013; 4: 72
        • Volkow ND
        • Baler RD.
        Addiction science: Uncovering neurobiological complexity.
        Neuropharmacology. 2013;
        • Volkow ND
        • Wang GJ
        • Fowler JS
        • Tomasi D.
        Addiction circuitry in the human brain.
        Annu Rev Pharmacol Toxicol. 2012; 52: 321-336
        • Koob GF
        • Volkow ND.
        Neurocircuitry of addiction.
        Neuropsychopharmacology. 2010; 35: 217-238
        • Upadhyay J
        • Maleki N
        • Potter J
        • et al.
        Alterations in brain structure and functional connectivity in prescription opioid-dependent patients.
        Brain. 2010; 133: 2098-2114
        • Zijlstra F
        • Veltman DJ
        • Booij J
        • van den Brink W
        • Franken IH.
        Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males.
        Drug Alcohol Depend. 2009; 99: 183-192
        • Wang W
        • Wang YR
        • Qin W
        • et al.
        Changes in functional connectivity of ventral anterior cingulate cortex in heroin abusers.
        Chin Med J (Engl). 2010; 123: 1582-1588
        • Younger JW
        • Chu LF
        • D'Arcy NT
        • Trott KE
        • Jastrzab LE
        • Mackey SC
        Prescription opioid analgesics rapidly change the human brain.
        Pain. 2011; 152: 1803-1810
        • Lin JC
        • Chu LF
        • Stringer EA
        • et al.
        One month of oral morphine decreases gray matter volume in the right amygdala of individuals with low back pain: confirmation of previously reported magnetic resonance imaging results.
        Pain Med. 2016; 17: 1497-1504
        • McConnell PA
        • Garland EL
        • Zubieta JK
        • Newman-Norlund R
        • Powers S
        • Froeliger B.
        Impaired frontostriatal functional connectivity among chronic opioid using pain patients is associated with dysregulated affect.
        Addict Biol. 2020; 25: e12743
        • Heller AS
        • Johnstone T
        • Light SN
        • et al.
        Relationships between changes in sustained fronto-striatal connectivity and positive affect in major depression resulting from antidepressant treatment.
        Am J Psychiatry. 2013; 170: 197-206
        • Heller AS
        • Johnstone T
        • Shackman AJ
        • et al.
        Reduced capacity to sustain positive emotion in major depression reflects diminished maintenance of fronto-striatal brain activation.
        Proc Natl Acad Sci U S A. 2009; 106: 22445-22450
        • Drysdale AT
        • Grosenick L
        • Downar J
        • et al.
        Resting-state connectivity biomarkers define neurophysiological subtypes of depression.
        Nat Med. 2017; 23: 28-38
        • Roy M
        • Shohamy D
        • Wager TD.
        Ventromedial prefrontal-subcortical systems and the generation of affective meaning.
        Trends Cogn Sci. 2012; 16: 147-156
        • Froeliger B
        • McConnell PA
        • Stankeviciute N
        • McClure EA
        • Kalivas PW
        • Gray KM.
        The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: a double-blind, placebo-controlled fMRI pilot study.
        Drug Alcohol Depend. 2015; 156: 234-242
        • Zhang S
        • Li CR.
        Ventral striatal dysfunction in cocaine dependence - difference mapping for subregional resting state functional connectivity.
        Transl Psychiatry. 2018; 8: 119
        • Hiser J
        • Koenigs M.
        The multifaceted role of the ventromedial prefrontal cortex in emotion, decision making, social cognition, and psychopathology.
        Biol Psychiatry. 2018; 83: 638-647
        • Zald DH
        • Mattson DL
        • Pardo JV.
        Brain activity in ventromedial prefrontal cortex correlates with individual differences in negative affect.
        Proc Natl Acad Sci U S A. 2002; 99: 2450-2454
        • Shackman AJ
        • Salomons TV
        • Slagter HA
        • Fox AS
        • Winter JJ
        • Davidson RJ.
        The integration of negative affect, pain and cognitive control in the cingulate cortex.
        Nat Rev Neurosci. 2011; 12: 154-167
        • Etkin A
        • Wager TD.
        Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia.
        Am J Psychiatry. 2007; 164: 1476-1488
        • Garland EL
        • Froeliger B
        • Howard MO.
        Allostatic dysregulation of natural reward processing in prescription opioid misuse: autonomic and attentional evidence.
        Biol Psychol. 2015; 105: 124-129
        • Garland EL
        • Froeliger B
        • Howard MO.
        Effects of Mindfulness-Oriented Recovery Enhancement on reward responsiveness and opioid cue-reactivity.
        Psychopharmacology (Berl). 2014; 231: 3229-3238
        • Elman I
        • Upadhyay J
        • Langleben DD
        • Albanese M
        • Becerra L
        • Borsook D.
        Reward and aversion processing in patients with post-traumatic stress disorder: functional neuroimaging with visual and thermal stimuli.
        Transl Psychiatry. 2018; 8: 240
        • Pechtel P
        • Dutra SJ
        • Goetz EL
        • Pizzagalli DA.
        Blunted reward responsiveness in remitted depression.
        J Psychiatr Res. 2013; 47: 1864-1869
        • Hanley AW
        • Garland EL.
        Salivary measurement and mindfulness-based modulation of prescription opioid cue-reactivity.
        Drug Alcohol Depend. 2020; 217108351
        • Garland EL
        • Bryan CJ
        • Kreighbaum L
        • Nakamura Y
        • Howard MO
        • Froeliger B.
        Prescription opioid misusing chronic pain patients exhibit dysregulated context-dependent associations: Investigating associative learning in addiction with the cue-primed reactivity task.
        Drug Alcohol Depend. 2018; 187: 13-21
        • Kakko J
        • Alho H
        • Baldacchino A
        • Molina R
        • Nava FA
        • Shaya G.
        Craving in opioid use disorder: from neurobiology to clinical practice.
        Front Psychiatry. 2019; 10: 592
        • Shi J
        • Li SX
        • Zhang XL
        • et al.
        Time-dependent neuroendocrine alterations and drug craving during the first month of abstinence in heroin addicts.
        Am J Drug Alcohol Abuse. 2009; 35: 267-272
        • Gerra G
        • Ceresini S
        • Esposito A
        • et al.
        Neuroendocrine and behavioural responses to opioid receptor-antagonist during heroin detoxification: relationship with personality traits.
        Int Clin Psychopharmacol. 2003; 18: 261-269
        • Garavan H
        • Stout JC.
        Neurocognitive insights into substance abuse.
        Trends Cogn Sci. 2005; 9: 195-201
        • Kaufman JN
        • Ross TJ
        • Stein EA
        • Garavan H.
        Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging.
        J Neurosci. 2003; 23: 7839-7843
        • Hester R
        • Garavan H.
        Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity.
        J Neurosci. 2004; 24: 11017-11022
        • Bolla KI
        • Eldreth DA
        • London ED
        • et al.
        Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task.
        Neuroimage. 2003; 19: 1085-1094
        • Bolla KI
        • Eldreth DA
        • Matochik JA
        • Cadet JL.
        Neural substrates of faulty decision-making in abstinent marijuana users.
        Neuroimage. 2005; 26: 480-492
        • Kendall SE
        • Sjøgren P
        • Pimenta CA
        • Højsted J
        • Kurita GP.
        The cognitive effects of opioids in chronic non-cancer pain.
        Pain. 2010; 150: 225-230
        • Jamison RN
        • Edwards RR.
        Risk factor assessment for problematic use of opioids for chronic pain.
        Clin Neuropsychol. 2013; 27: 60-80
        • Garland EL
        • Froeliger B
        • Zeidan F
        • Partin K
        • Howard MO.
        The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways.
        Neurosci Biobehav Rev. 2013; 37: 2597-2607
        • Garland EL
        • Froeliger BE
        • Passik SD
        • Howard MO.
        Attentional bias for prescription opioid cues among opioid dependent chronic pain patients.
        J Behav Med. 2013; 36: 611-620
        • Jamison RN
        • Sheehan KA
        • Scanlan E
        • Matthews M
        • Ross EL.
        Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers.
        J Opioid Manag. 2014; 10: 375-382
        • Jamison RN
        • Martel MO
        • Edwards RR
        • Qian J
        • Sheehan KA
        • Ross EL.
        Validation of a brief Opioid Compliance Checklist for patients with chronic pain.
        J Pain. 2014; 15: 1092-1101
        • Braden JB
        • Sullivan MD
        • Ray GT
        • et al.
        Trends in long-term opioid therapy for noncancer pain among persons with a history of depression.
        Gen Hosp Psychiatry. 2009; 31: 564-570
        • Edlund MJ
        • Martin BC
        • Devries A
        • Fan MY
        • Braden JB
        • Sullivan MD.
        Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study.
        Clin J Pain. 2010; 26: 1-8
        • Sullivan MD.
        Depression effects on long-term prescription opioid use, abuse, and addiction.
        Clin J Pain. 2018; 34: 878-884
        • Sullivan MD.
        Who gets high-dose opioid therapy for chronic non-cancer pain?.
        Pain. 2010; 151: 567-568
        • Sullivan MD
        • Howe CQ.
        Opioid therapy for chronic pain in the United States: promises and perils.
        Pain. 2013; 154: S94-100
        • Ballantyne JC.
        Opioids for the treatment of chronic pain: mistakes made, lessons learned, and future directions.
        Anesth Analg. 2017; 125: 1769-1778
        • Halbert BT
        • Davis RB
        • Wee CC.
        Disproportionate longer-term opioid use among U.S. adults with mood disorders.
        Pain. 2016; 157: 2452-2457
        • Busse JW
        • Craigie S
        • Juurlink DN
        • Buckley DN
        • Wang L
        • Couban RJ
        • et al.
        Guideline for opioid therapy and chronic noncancer pain.
        Cmaj. 2017; 189: E659-EE66
        • Dowell D
        • Haegerich TM
        • Chou R.
        CDC guideline for prescribing opioids for chronic pain - United States, 2016.
        MMWR Recomm Rep. 2016; 65: 1-49
        • Martel M
        • Jamison R.
        Adherence in Pharmacotherapy: Maximizing Benefit and Minimizing Risk. Facilitating Treatment Adherence in Pain Medicine.
        Oxford University Press, 2017: 31-57
        • Dowell D
        • Haegerich TM
        • Chou R.
        CDC Guideline for Prescribing Opioids for Chronic Pain–United States, 2016.
        Jama. 2016; 315: 1624-1645
        • Dowell D
        • Haegerich T
        • Chou R.
        No shortcuts to safer opioid prescribing.
        N Engl J Med. 2019; 380: 2285-2287
        • Williams ACC
        • Fisher E
        • Hearn L
        • Eccleston C.
        Psychological therapies for the management of chronic pain (excluding headache) in adults.
        Cochrane Database Syst Rev. 2020; 8Cd007407
        • McHugh RK
        • Hearon BA
        • Otto MW.
        Cognitive behavioral therapy for substance use disorders.
        Psychiatr Clin North Am. 2010; 33: 511-525
        • Dutra L
        • Stathopoulou G
        • Basden SL
        • Leyro TM
        • Powers MB
        • Otto MW.
        A meta-analytic review of psychosocial interventions for substance use disorders.
        Am J Psychiatry. 2008; 165: 179-187
        • Magill M
        • Ray LA.
        Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials.
        J Stud Alcohol Drugs. 2009; 70: 516-527
        • Jamison RN
        • Ross EL
        • Michna E
        • Chen LQ
        • Holcomb C
        • Wasan AD.
        Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial.
        Pain. 2010; 150: 390-400
        • Starrels JL
        • Becker WC
        • Alford DP
        • Kapoor A
        • Williams AR
        • Turner BJ.
        Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain.
        Ann Intern Med. 2010; 152: 712-720
        • Turner JA
        • Saunders K
        • Shortreed SM
        • et al.
        Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.
        J Gen Intern Med. 2014; 29: 305-311
        • Chou R
        • Fanciullo GJ
        • Fine PG
        • Miaskowski C
        • Passik SD
        • Portenoy RK.
        Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline.
        J Pain. 2009; 10: 131-146
        • Katz NP
        • Sherburne S
        • Beach M
        • Rose RJ
        • Vielguth J
        • Bradley J
        • et al.
        Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy.
        Anesth Analg. 2003; 97 (table of contents): 1097-1102
        • Cheatle MD.
        Biopsychosocial approach to assessing and managing patients with chronic pain.
        Med Clin North Am. 2016; 100: 43-53
        • Guarino H
        • Fong C
        • Marsch LA
        • et al.
        Web-based cognitive behavior therapy for chronic pain patients with aberrant drug-related behavior: outcomes from a randomized controlled trial.
        Pain Med. 2018; 19: 2423-2437
        • Jamison RN
        • Jurcik DC
        • Edwards RR
        • Huang CC
        • Ross EL.
        A pilot comparison of a smartphone app with or without 2-way messaging among chronic pain patients: who benefits from a pain app?.
        Clin J Pain. 2017; 33: 676-686
        • Eccleston C
        • Blyth FM
        • Dear BF
        • et al.
        Managing patients with chronic pain during the COVID-19 outbreak: considerations for the rapid introduction of remotely supported (eHealth) pain management services.
        Pain. 2020; 161: 889-893
        • Lagman-Bartolome AM
        • Lawler V
        • Lay C.
        Headache education active-waiting directive: a program to enhance well-being during long referral wait times.
        Headache. 2018; 58: 109-117
        • McCauley JL
        • Back SE
        • Brady KT.
        Pilot of a brief, web-based educational intervention targeting safe storage and disposal of prescription opioids.
        Addict Behav. 2013; 38: 2230-2235
        • Chang Y-P
        • Compton P
        • Almeter P
        • Fox CH.
        The effect of motivational interviewing on prescription opioid adherence among older adults with chronic pain.
        Perspect Psychiatric Care. 2015; 51: 211-219
        • Sullivan MD
        • Turner JA
        • DiLodovico C
        • D'Appollonio A
        • Stephens K
        • Chan YF
        Prescription opioid taper support for outpatients with chronic pain: a randomized controlled trial.
        J Pain. 2017; 18: 308-318
        • Darnall BD
        • Ziadni MS
        • Stieg RL
        • Mackey IG
        • Kao MC
        • Flood P.
        Patient-Centered Prescription Opioid Tapering in Community Outpatients With Chronic Pain.
        JAMA Intern Med. 2018; 178: 707-708
        • McCracken LM
        • Vowles KE.
        Acceptance and commitment therapy and mindfulness for chronic pain: model, process, and progress.
        Am Psychol. 2014; 69: 178-187
        • McCracken LM
        • Morley S.
        The psychological flexibility model: a basis for integration and progress in psychological approaches to chronic pain management.
        J Pain. 2014; 15: 221-234
        • Witkiewitz K
        • Bowen S
        • Douglas H
        • Hsu SH.
        Mindfulness-based relapse prevention for substance craving.
        Addict Behav. 2013; 38: 1563-1571
        • Witkiewitz K
        • Lustyk MKB
        • Bowen S.
        Retraining the addicted brain: a review of hypothesized neurobiological mechanisms of mindfulness-based relapse prevention.
        Psychol Addict Behav. 2013; 27: 351-365
        • Garland EL
        • Brintz CE
        • Hanley AW
        • Roseen EJ
        • Atchley RM
        • Gaylord SA
        • Faurot KR
        • Yaffe J
        • Fiander M
        • Keefe FJ.
        Mind-Body Therapies for Opioid-Treated Pain: A Systematic Review and Meta-analysis.
        JAMA Intern Med. 2019 Nov 4; 180: 91-105https://doi.org/10.1001/jamainternmed.2019.4917
        • Garland EL
        • Manusov EG
        • Froeliger B
        • Kelly A
        • Williams JM
        • Howard MO.
        Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: Results from an early-stage randomized controlled trial.
        J Consult Clin Psychol. 2014; 82: 448-459
        • Garland EL
        • Froeliger B
        • Howard MO.
        Neurophysiological evidence for remediation of reward processing deficits in chronic pain and opioid misuse following treatment with Mindfulness-Oriented Recovery Enhancement: exploratory ERP findings from a pilot RCT.
        J Behav Med. 2015; 38: 327-336
        • Garland EL
        • Bryan CJ
        • Finan PH
        • Thomas EA
        • Priddy SE
        • Riquino MR
        • et al.
        Pain, hedonic regulation, and opioid misuse: modulation of momentary experience by mindfulness-oriented recovery Enhancement in opioid-treated chronic pain patients.
        Drug Alcohol Depend. 2017; 173: S65-S72
        • Garland EL
        • Hudak J
        • Hanley AW
        • Nakamura Y.
        Mindfulness-oriented recovery enhancement reduces opioid dose in primary care by strengthening autonomic regulation during meditation.
        Am Psychol. 2020; 75: 840-852
        • Vowles KE
        • Witkiewitz K
        • Cusack KJ
        • et al.
        Integrated behavioral treatment for veterans with co-morbid chronic pain and hazardous opioid use: a randomized controlled pilot trial.
        J Pain. 2020; 21: 798-807